MEC Plus Full List ViewBy pinki@katapult.biz / February 16, 2025 MEC Plus Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignant Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Oral Cancer Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title Type of Media — Video Document Audio Events — 2024 California Cancer Consortium Conference (CCC) 2024 MCM 2024 MCM 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Search Entries: Clear « 1 … 29 30 31 32 33 … 115 » Validation of a Mathematic 3D-liver Model to Predict the Most Suitable Local Treatment Option for Colorectal Liver Metastases (CRLM): Recommendations from the COLLISION Expert Panel Bente van den Bemd, MD View PDF Three-Dimensional Rotational Angiography (3DRA) Assisted Cone Beam Computed Tomography (CBCT) Guided Microwave Ablation (MWA) in the Treatment of Hepatic Malignancy Benjamin Daniel, MD View PDF Thrombectomy in Cancer patients Osman Ahmed, MD View PDF DVT management in the oncologic population Varshana Gurusamy, MD View PDF Acute Limb Ischemia in the cancer population Olekandra Kutsenko, MD View PDF Choosing between locoregional treatment options for metastatic NE tumors Ricardo Garcia-Monaco, MD, PhD View PDF Eye 90- The next frontier in SIRT? Nadine Abi-Jaoudeh, MD View PDF Incorporating Y-90 into the mCRC treatment algorithm Ripal Gandhi, MD View PDF Y-90 Dosimetry concepts David Liu, MD View PDF Prospective trial of DEBIRI with 30-60 micron microspheres Katerina Malagari, MD View PDF Minimally Invasive to Noninvasive- HOPE 4 LIVER Results Govindarajan Narayanan, MD View PDF Pushing the boundaries with stereotactic Ablation Reto Bale, MD View PDF Lessons learnt from the AMCORE registry Robbert Puijk, MD, PhD View PDF The ACCLAIM trial Costantinos Sofocleous, MD, PhD View PDF Chemotherapeutic advances in mCRC Antonio Ucar, MD View PDF Getting the mCRC patient to surgery – Role of PVE & HVD Ripal Gandhi, MD View PDF Surgical strategies in mCRC Domenech Asbun, MD View PDF B-Cell NHL (Low-Grades) Loretta Nastoupil, MD View PDF B-Cell NHL (Aggressive) - Relapsed (CAR T versus Bispecifics?) Julio C. Chavez, MD View PDF T-Cell NHL- Novel Therapies Francine Foss, MD View PDF Myelodysplasia: De Novo and Acquired- What To Do? Guillermo Garcia-Manero, MD View PDF Acute Myeloid Leukemia Catherine Lai, MD View PDF Chronic Lymphocytic Leukemia Javier Pinilla-Ibarz, MD View PDF Updates in Waldenstrom’s Macroglobulinemia Jorge Castillo, MD View PDF Novel Advances in Multiple Myeloma as Front-Line Therapy Ivan M. Borrello, MD View PDF
